Hyderabad News Desk

As per DelveInsight’s assessment, the Implantable Drug Delivery Devices Market is expected to grow at an immense pace in the coming years owing to the The increasing prevalence of pandemic such as COVID-19, Pre- and post-operation and some few of the other applications where Implantable Drug Delivery Devices have been used, which is expected to drive the demand for Implantable Drug Delivery Devices in the upcoming years.

DelveInsight’s “Implantable Drug Delivery Devices Market” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.  The report also covers the major emerging products and key Implantable Drug Delivery Devices companies actively working in the market.

Implantable Drug Delivery Devices

Implantable drug delivery devices are specialized medical devices designed to administer medications, therapeutic agents, or drugs directly into the body over an extended period. These devices are implanted inside the body and are programmed to release specific doses of medication at predetermined rates or intervals.

Implantable Drug Delivery Devices Market Insights

In 2022, North America is projected to hold the most significant portion of the implantable drug delivery devices market compared to other regions. This dominance can be attributed to several factors. These include the increasing occurrence of chronic diseases, a growing elderly population susceptible to such conditions, swift adoption of advanced technology-driven products, a rising preference for minimally invasive procedures, continual introduction of innovative products by industry leaders, the strong presence of key market players, higher disposable incomes, and a well-established awareness regarding sustained and controlled drug delivery systems. These combined factors are anticipated to drive the market growth of implantable drug delivery devices in North America.

Therefore, these aforementioned factors are expected to contribute to the growth of the implantable drug delivery devices market in North America throughout the forecasted period from 2023 to 2028.

DelveInsight Implantable Drug Delivery Devices Market Size Analysis: The Global Implantable Drug Delivery Devices market size is anticipated to grow with a CAGR of 6.31% during the forecasted period (2023-2028)

To know more about why North America is leading the market growth in the Implantable Drug Delivery Devices market, get a snapshot of the report Implantable Drug Delivery Devices Market Trends

https://www.delveinsight.com/report-store/implantable-drug-delivery-devices-market

Recent Developments in the Implantable Drug Delivery Devices Market Report

• In August 2022, Baxter International has obtained approval (510(k) clearance) from the FDA in the United States for its fresh Novum IQ syringe infusion pump along with Dose IQ safety software. This signifies Baxter’s most recent advancements in infusion therapy.
• In August 2022, Medtronic introduced the Onyx Frontier drug-eluting coronary stent subsequent to obtaining CE Mark approval. This stent incorporates an inventive delivery mechanism and expands upon the Resolute Onyx drug-eluting stent’s acute performance and clinical findings.
• In February 2021, The Remunity Pump for Remodulin, designed for individuals with pulmonary arterial hypertension, was commercially released by United Therapeutics Corporation. This compact and inconspicuous pump administers Remodulin through prefilled cassettes directly to patients, presenting notable enhancements in delivery.
• Thus, owing to such developments in the market, rapid growth will be observed in the Implantable Drug Delivery Devices market during the forecast period

To read more about the latest highlights related to Implantable Drug Delivery Devices, get a snapshot of the key highlights entailed in the Implantable Drug Delivery Devices Market Forecast

Key Players in the Implantable Drug Delivery Devices Market

Some of the key Implantable Drug Delivery Devices companies operating in the market include- Delpor, Inc., Medtronic, ABBVIE INC., Boston Scientific Corporation, Bausch & Lomb Incorporated, Alcon, BIOTRONIK, Terumo Corporation, Bayer AG, Teleflex Incorporated, Abbott, Merck & Co., Inc., ORGANON, Flowonix Medical, Inc., Fresenius Kabi AG, and others.

Drug Delivery Devices Market Dynamics:

The increasing demand for implantable drug delivery devices is being driven by several factors, with one significant contributor being the escalating prevalence of diabetes, a chronic ailment. According to the International Diabetes Federation’s 2022 report, approximately 537 million individuals globally were living with diabetes in 2021. Projections from the same source indicate an estimated rise to about 643 million by 2030 and approximately 783 million by 2045 in the number of people affected by diabetes. Patients managing diabetes often require frequent painful insulin injections to regulate their blood glucose levels. Recently introduced, an adapted titanium implant known as the implant-mediated drug delivery system (IMDDS) offers sustained drug delivery without the need for needles. Consequently, due to the increasing diabetic population, there will be heightened demand for implantable drug delivery devices specifically designed for insulin delivery among these patients, ultimately fostering the overall growth of the implantable drug delivery devices market.

Yet, the growth of the implantable drug delivery devices market might be constrained by stringent regulatory demands, complications associated with different devices, and other limiting factors.

Scope of the Implantable Drug Delivery Devices Market Report

• Coverage: Global
• Study Period: 2020–2028
• Implantable Drug Delivery Devices Market Segmentation By Product Type: Drug Infusion Pumps, Intraocular Drug Delivery Devices, Contraceptive Drug Delivery Devices, Implantable Stents, and Others
• Implantable Drug Delivery Devices Market Segmentation By Type: Biodegradable Implants and Non-Biodegradable Implants), Application (Oncology, Cardiology, Gynecology, Auto-Immune Diseases, and Others
• Implantable Drug Delivery Devices Market Application Type: Oncology, Cardiology, Gynecology, Auto-Immune Diseases, and Others
• Implantable Drug Delivery Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Implantable Drug Delivery Devices Companies: Delpor, Inc., Medtronic, ABBVIE INC., Boston Scientific Corporation, Bausch & Lomb Incorporated, Alcon, BIOTRONIK, Terumo Corporation, Bayer AG, Teleflex Incorporated, Abbott, Merck & Co., Inc., ORGANON, Flowonix Medical, Inc., Fresenius Kabi AG, and others
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the Implantable Drug Delivery Devices market are set to emerge as the trendsetter explore @ Implantable Drug Delivery Devices Market Trends

Table of Contents 

Interested in knowing how the Implantable Drug Delivery Devices market will grow by 2027? Click to get a snapshot of the Implantable Drug Delivery Devices Market Analysis

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services